Table 5.
Data for 10-year survival in longterm survivors (survival ≥5 years) of periampullary adenocarcinomas after pancreaticoduodenectomy
| Survival, months, median (range) | Actuarial 10-year survival | Patients alive, n | |
|---|---|---|---|
| Periampullary adenocarcinomas (n = 109) | 137.3 (60.8–341.1) | 73.2% | 56 |
| Pancreatic head adenocarcinoma (n = 11) | 112.5 (60.8–293.7) | 49.1% | 2 |
| Ampullary adenocarcinoma (n = 83) | 143.9 (62.4–341.1) | 74.4% | 46 |
| Distal CBD adenocarcinoma (n = 10) | 137.1 (62.0–208.1) | 87.5% | 7 |
| Duodenal adenocarcinoma (n = 5) | 84.4 (60.8–341.1) | 50.0% | 1 |
CBD, common bile duct.